What is the difference between Kisspeptin-54 and Leuprolide?

Kisspeptin-54: Full-length kisspeptin (54 amino acids); binds KISS1R on GnRH neurons with higher receptor occupancy and longer duration than KP-10; induces more sustained GnRH/LH pulses Leuprolide: Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels.

Is Kisspeptin-54 FDA approved?

Kisspeptin-54 is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

Is Leuprolide FDA approved?

Leuprolide is FDA approved (FDA status current as of 1985-04-08). This regulatory status is provided for research and educational context only.

How is Kisspeptin-54 administered in research settings?

In research settings, Kisspeptin-54 is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

How is Leuprolide administered in research settings?

In research settings, Leuprolide is typically administered via the subcutaneous, intramuscular, or implant routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Kisspeptin-54 vs Leuprolide

Peptide Comparison

Kisspeptin-54 vs Leuprolide

Both are Reproductive & Hormonal peptides.

Kisspeptin-54

KP-54

Sexual HealthInvestigationalResearch Only

Half-life: ~29 minutes

12 providers listed

Full Kisspeptin-54 profile →

Leuprolide

Lupron

Sexual HealthFDA ApprovedPrescription

2 providers listed

Full Leuprolide profile →

Bottom line

Leuprolide is FDA-approved, while Kisspeptin-54 is investigational — the clearest structural difference between them.

Quick Verdict

Kisspeptin-54

Evidence

Established Clinical

Half-life

~29 minutes

Leuprolide

Evidence

Established Clinical

Half-life

—

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Leuprolide
Further along in FDA review	Leuprolide
More provider options (12 vs 2)	Kisspeptin-54

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Kisspeptin-54

Leuprolide

Mechanism Family

Reproductive & Hormonal

Half-life

~29 minutes

—

FDA Status

investigational

approved

Admin Routes

subcutaneous, intravenous

subcutaneous, intramuscular, implant

Availability

Research Only

Prescription

Providers

12 listed

2 listed

FDA Update

—

Apr 1985

Avail. Notes

No FDA approval. Longer-acting kisspeptin isoform under Phase 1/2 investigation for reproductive disorders in EU and US. No NDA filed. Research peptide only.

FDA-approved: Lupron (leuprolide acetate), Drugs@FDA application 019010.

Research Evidence

Kisspeptin-54

Established ClinicalRCT · 8 key studies · most recent 2025

Leuprolide

Established ClinicalMeta-analysis · 19 key studies · most recent 2026

Research Citations

Kisspeptin-54

Review2025 · Trends in Endocrinology and Metabolism

Can kisspeptin be a new treatment for sexual dysfunction?

Cohort2025 · Journal of Endocrinological Investigation

Phase-dependent changes in serum kisspeptin and irisin levels across the menstrual cycle in healthy women

RCT2022 · JAMA Netw Open

Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical T…

Cohort2020 · Endocrine

Kisspeptin and LH pulsatility in patients with functional hypothalamic amenorrhea

+4 more

Leuprolide

Meta-analysis2024 · J Minim Invasive Gynecol

The Effect of Hormonal Treatment on Ovarian Endometriomas: A Systematic Review and Meta-Analysis

RCT1993 · Am J Obstet Gynecol

Depot leuprolide vs danazol for endometriosis: multicenter double-blind RCT

RCT1984 · New England Journal of Medicine

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

Cohort2026 · Int J Mol Sci

Terazosin as a Non-Hormonal Treatment for Endometriosis.

+15 more

About Kisspeptin-54

Full-length kisspeptin (54 amino acids); binds KISS1R on GnRH neurons with higher receptor occupancy and longer duration than KP-10; induces more sustained GnRH/LH pulses

Research Areas

sustained LH/FSH stimulationtestosterone supportfertility inductionreproductive function

About Leuprolide

Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels. Short-term pulsatile use can transiently stimulate the axis before suppression occurs.

Research Areas

HPG axis modulationtestosterone suppressionhormonal restartGnRH axis control

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Kisspeptin-54

Reported (Unverified — Pending Clinical Review)

hormone-sensitive cancerspregnancy (during treatment)

No established clinical contraindications

Leuprolide

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Find Providers

Where to source these peptides

Providers offering

Kisspeptin-54

12 listed

Browse directory →

Providers offering

Leuprolide

2 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Reproductive & Hormonal Comparisons

Browse all peptides →

Educational research tools — not medical advice.